國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

In vivo reprogramming in regenerativ...

SpringerLink (Online service)

In vivo reprogramming in regenerative medicine

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	In vivo reprogramming in regenerative medicineedited by Acelya Yilmazer.
其他作者:	Yilmazer, Acelya.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	xvii, 103 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Regenerative medicine.
電子資源:	http://dx.doi.org/10.1007/978-3-319-65720-2
ISBN:	9783319657202$q(electronic bk.)

In vivo reprogramming in regenerative medicine
In vivo reprogramming in regenerative medicine[electronic resource] /edited by Acelya Yilmazer. - Cham :Springer International Publishing :2017. - xvii, 103 p. :ill., digital ;24 cm. - Stem cell biology and regenerative medicine,2196-8985. - Stem cell biology and regenerative medicine..

Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.

There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.

ISBN: 9783319657202$q(electronic bk.)

Standard No.: 10.1007/978-3-319-65720-2doiSubjects--Topical Terms:

339384
Regenerative medicine.

LC Class. No.: R856

Dewey Class. No.: 610.28

In vivo reprogramming in regenerative medicine
LDR:02465nmm a2200325 a 4500 001 524973
003 DE-He213
005 20180511134159.0
006 m d
007 cr nn 008maaau
008 180904s2017 gw s 0 eng d
020 $a 9783319657202$q(electronic bk.)
020 $a 9783319657196$q(paper)
024 7 $a 10.1007/978-3-319-65720-2 $2 doi
035 $a 978-3-319-65720-2
040 $a GP $c GP
041 0 $a eng
050 4 $a R856
072 7 $a PSF $2 bicssc
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 610.28 $2 23
090 $a R856 $b .I35 2017
245 0 0 $a In vivo reprogramming in regenerative medicine $h [electronic resource] / $c edited by Acelya Yilmazer.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2017.
300 $a xvii, 103 p. : $b ill., digital ; $c 24 cm.
490 1 $a Stem cell biology and regenerative medicine, $x 2196-8985
505 0 $a Chapter 1. Introduction to in vivo cell Reprogramming Technology -- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells -- Chapter 3. Direct Reprogramming to Beta Cells -- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration -- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency -- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration -- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.
520 $a There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic.
650 0 $a Regenerative medicine. $3 339384
650 1 4 $a Life Sciences. $3 273679
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 675875
650 2 4 $a Stem Cells. $3 203924
650 2 4 $a Cell Culture. $3 337771
650 2 4 $a Transplant Surgery. $3 275145
700 1 $a Yilmazer, Acelya. $3 797054
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Stem cell biology and regenerative medicine. $3 558395
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-65720-2
950 $a Biomedical and Life Sciences (Springer-11642)